283 related articles for article (PubMed ID: 17212106)
1. [Analysis of long-term (5-year) survival in patients with metastatic breast cancer to the liver].
Kan N
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1780-4. PubMed ID: 17212106
[TBL] [Abstract][Full Text] [Related]
2. Patterns of relapse and metastatic spread in HER2-overexpressing breast cancer according to estrogen receptor status.
Park YH; Lee S; Cho EY; Choi YL; Lee JE; Nam SJ; Yang JH; Ahn JS; Im YH
Cancer Chemother Pharmacol; 2010 Aug; 66(3):507-16. PubMed ID: 19956951
[TBL] [Abstract][Full Text] [Related]
3. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
4. Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis.
Pawlik TM; Gleisner AL; Bauer TW; Adams RB; Reddy SK; Clary BM; Martin RC; Scoggins CR; Tanabe KK; Michaelson JS; Kooby DA; Staley CA; Schulick RD; Vauthey JN; Abdalla EK; Curley SA; Choti MA; Elias D
Ann Surg Oncol; 2007 Oct; 14(10):2807-16. PubMed ID: 17551795
[TBL] [Abstract][Full Text] [Related]
5. Curative liver resection for metastatic breast cancer.
Maksan SM; Lehnert T; Bastert G; Herfarth C
Eur J Surg Oncol; 2000 Apr; 26(3):209-12. PubMed ID: 10753531
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for patients with liver metastases from breast cancer.
Eichbaum MH; Kaltwasser M; Bruckner T; de Rossi TM; Schneeweiss A; Sohn C
Breast Cancer Res Treat; 2006 Mar; 96(1):53-62. PubMed ID: 16319993
[TBL] [Abstract][Full Text] [Related]
7. [Clinical characteristics and prognosis of triple-negative breast cancer: a report of 305 cases].
Yuan ZY; Wang SS; Gao Y; Su ZY; Luo WB; Guan ZZ
Ai Zheng; 2008 Jun; 27(6):561-5. PubMed ID: 18570725
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.
Saiura A; Umekita N; Inoue S; Maeshiro T; Miyamoto S; Matsui Y; Asakage M; Kitamura M
Hepatogastroenterology; 2002; 49(46):1062-5. PubMed ID: 12143202
[TBL] [Abstract][Full Text] [Related]
9. [Retrospective analysis of 98 cases of breast cancer with liver metastasis].
Zhu MQ; Zhang DS; Su ZY; Shi YX; Peng RJ; Zhou NN; Liu DG; Jiang WQ
Ai Zheng; 2007 Apr; 26(4):423-6. PubMed ID: 17430666
[TBL] [Abstract][Full Text] [Related]
10. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
11. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes.
Carey LA; Dees EC; Sawyer L; Gatti L; Moore DT; Collichio F; Ollila DW; Sartor CI; Graham ML; Perou CM
Clin Cancer Res; 2007 Apr; 13(8):2329-34. PubMed ID: 17438091
[TBL] [Abstract][Full Text] [Related]
12. HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients.
Wülfing P; Borchard J; Buerger H; Heidl S; Zänker KS; Kiesel L; Brandt B
Clin Cancer Res; 2006 Mar; 12(6):1715-20. PubMed ID: 16551854
[TBL] [Abstract][Full Text] [Related]
13. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy.
Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B
Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases.
Vlastos G; Smith DL; Singletary SE; Mirza NQ; Tuttle TM; Popat RJ; Curley SA; Ellis LM; Roh MS; Vauthey JN
Ann Surg Oncol; 2004 Sep; 11(9):869-74. PubMed ID: 15342348
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of multimodality therapy for synchronous liver metastases of gastric cancer].
Sasaki H; Ninomiya M; Yano S; Umeoka T; Harano M; Aoki H; Onoda T; Shiozaki S; Ohno S; Higaki K; Takakura N
Gan To Kagaku Ryoho; 2004 Oct; 31(11):1924-6. PubMed ID: 15553761
[TBL] [Abstract][Full Text] [Related]
16. Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast.
Elias D; Lasser P; Spielmann M; May-Levin F; el Malt O; Thomas H; Mouriesse H
Surg Gynecol Obstet; 1991 Jun; 172(6):461-4. PubMed ID: 2035135
[TBL] [Abstract][Full Text] [Related]
17. Long-term characteristics of 5-year survivors after liver resection for colorectal metastases.
Tanaka K; Shimada H; Ueda M; Matsuo K; Endo I; Togo S
Ann Surg Oncol; 2007 Apr; 14(4):1336-46. PubMed ID: 17235718
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary metastases of breast cancer. When is resection indicated?
Welter S; Jacobs J; Krbek T; Tötsch M; Stamatis G
Eur J Cardiothorac Surg; 2008 Dec; 34(6):1228-34. PubMed ID: 18824371
[TBL] [Abstract][Full Text] [Related]
19. Disparities in the survival improvement of recurrent breast cancer.
Anan K; Mitsuyama S; Koga K; Tanabe R; Saimura M; Tanabe Y; Watanabe M; Suehara N; Matsunaga H; Nishihara K; Abe Y; Nakano T; Tamae K; Ono M; Toyoshima S
Breast Cancer; 2010; 17(1):48-55. PubMed ID: 19350357
[TBL] [Abstract][Full Text] [Related]
20. The utility of estrogen receptor, progesterone receptor, and Her-2/neu status to predict survival in patients undergoing hepatic resection for breast cancer metastases.
Martinez SR; Young SE; Giuliano AE; Bilchik AJ
Am J Surg; 2006 Feb; 191(2):281-3. PubMed ID: 16442961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]